Press release
US Diabetic Retinopathy Market Growth: Technological Advancements in Retinal Imaging and Anti-VEGF Therapies | Leading Companies Include Bayer, Alimera Sciences, and Roche
Diabetic Retinopathy
Diabetic retinopathy, a condition where high blood sugar damages the retina's blood vessels, is a leading cause of blindness in working-age adults. With many patients experiencing little to no symptoms until vision loss has begun, early diagnosis tools such as dilated eye exams, optical coherence tomography (OCT), and fluorescein angiography are becoming critical. Treatments like laser therapy, intraocular steroid injections, and vitrectomy are evolving rapidly. As screening becomes more accessible and therapies more precise, the diabetic retinopathy market is emerging as a key segment in the global ophthalmic care ecosystem, combining innovation with urgent patient need.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/diabetic-retinopathy-market?sai-v
The Diabetic Retinopathy Market focuses on treatments, diagnostics, and technologies aimed at preventing and managing vision loss caused by diabetes-related retinal damage.
Key Players:
=> Major key players in the diabetic retinopathy market are Abbott Laboratories, Alimera Science, Allergan plc, Ampio Pharmaceuticals, Bayer AG, Hoffmann-La Roche, Novartis International AG, Glycadia Pharmaceuticals, Regeneron Pharmaceuticals Inc and Valeant Pharmaceutical.
Key Developments: Diabetic Retinopathy (U.S. & Japan)
♦ January 2025 (Japan): Santen Pharmaceutical initiated post-approval clinical programs for its long-acting anti-VEGF formulation, aiming to reduce injection frequency and enhance adherence in diabetic retinopathy and diabetic macular edema patients.
♦ September 2024 (U.S.): Regeneron reported positive Phase III outcomes for EYLEA HD (8 mg aflibercept), supporting dosing intervals of up to 16 weeks, improving patient convenience and treatment outcomes.
♦ January 2024 (Japan): Japan's Ministry of Health, Labour and Welfare approved the 8 mg aflibercept (EYLEA®) formulation for diabetic macular edema associated with diabetic retinopathy, introducing extended treatment intervals for clinical use.
Recent Mergers & Strategic Moves: Diabetic Retinopathy (U.S. & Japan)
♦ July 2025 (U.S.): Harrow Inc. completed the acquisition of exclusive U.S. rights from Samsung Bioepis for its ophthalmology biosimilar portfolio, including OPUVIZTM (aflibercept biosimilar) for diabetic retinopathy.
♦ May 2024 (U.S.): Merck & Co. acquired EyeBio Ltd. in a deal valued up to USD 3 billion, strengthening its late-stage ophthalmology pipeline targeting retinal vascular disorders such as diabetic retinopathy.
♦ March 2024 (Japan): Otsuka Pharmaceutical formed a collaboration with Riken and Keio University to advance gene-modulating therapeutic approaches for diabetic retinopathy, focusing on vascular protection and neuroinflammation control.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=diabetic-retinopathy-market?sai-v
Market Drivers - Diabetic Retinopathy Market
Rising Diabetes Cases: Growing global diabetes prevalence increases DR incidence.
Aging Population: Older demographics and sedentary lifestyles heighten risk.
Early Detection Initiatives: Government and private programs boost screening rates.
Tech Advancements: AI-based imaging and improved anti-VEGF therapies enhance diagnosis and treatment.
Healthcare Support: Expanding infrastructure and reimbursement policies drive market growth.
Industry Developments - Diabetic Retinopathy Market
AI-Powered Diagnostics: Wider use of AI for automated DR screening.
Long-Acting Drugs: Sustained-release anti-VEGF agents improving patient compliance.
Emerging Market Expansion: Asia-Pacific witnessing rapid adoption of DR treatments.
Innovative Surgeries: Advances in laser and vitrectomy techniques improving outcomes.
Collaborations: Pharma-tech partnerships accelerating new DR solutions.
Research Process:
Both primary and secondary data sources have been used in the Global Diabetic Retinopathy Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Key Segments:
➥ By Indication Type: Non-Proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy
➥ By Treatment Type: Anti-Vascular Endothelial Growth Factor (VEGF) Drug, Intraocular Steroid Injection, Laser Surgery, Vitrectomy
➥ By End User: Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/diabetic-retinopathy-market?sv
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US Diabetic Retinopathy Market Growth: Technological Advancements in Retinal Imaging and Anti-VEGF Therapies | Leading Companies Include Bayer, Alimera Sciences, and Roche here
News-ID: 4235292 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United State Digital Banking Solution Market to hit 8.62% CAGR to US$ 24.96 Bill …
Market Size and Forecast:
Global Digital Banking Solution Market reached US$ 13.04 billion in 2024 and is expected to reach US$ 24.96 billion by 2032, growing with a CAGR of 8.62% during the forecast period 2025-2032.
The Digital Banking Solutions Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed…
United States Smart Transportation Industry Growth, EV Charging 2025 | Leading C …
DataM Intelligence has published a new research report on "Smart Transportation Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample PDF Of This Report…
Thermal Printer Industry Booms | Growing Demand in Retail, Logistics, and Health …
DataM Intelligence has published a new research report on "Thermal Printer Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample PDF Of This Report…
US Vegan Yogurt Market Forecast: Increasing Consumption Driven by Lactose Intole …
The Global Vegan Yogurt Market reached USD 6.75 billion in 2024 and is expected to soar to around USD 12.09 billion by 2032, growing at a CAGR of 7.56% during the forecast period 2025-2032. This remarkable growth reflects the global surge in plant-based lifestyles, as consumers increasingly prioritize health, sustainability, and ethical food choices.
The market's momentum is powered by the growing shift toward dairy-free, lactose-free, and eco-conscious diets, with vegan…
More Releases for Diabetic
Diabetic Socks Market Dynamics Shaped by Rising Diabetic Population - Persistenc …
The diabetic socks market is gaining significant traction worldwide, driven by the rising prevalence of diabetes and related complications such as diabetic neuropathy and foot ulcers. Designed specifically to cater to the needs of diabetic patients, these socks play a crucial role in foot protection by preventing blistering, reducing moisture accumulation, and providing cushioning to minimize the risk of ulcers. This article delves deeply into the diabetic socks market, exploring…
Leading Element Driving Change in the Diabetic Footwear Market in 2025: Rising D …
Which drivers are expected to have the greatest impact on the over the diabetic footwear market's growth?
The surge in people with diabetes will spur the expansion of the diabetic footwear market in the future. Diabetes, characterised by high blood sugar levels, is a long-term health issue. Diabetic footwear can prevent severe foot-related issues caused by diabetes and offer several advantages such as enhanced blood flow, ample space for the toes,…
Diabetic Food Market
Future Market Insights (FMI) delivers key insights on the global diabetic food market in its latest report titled “Diabetic Food Market: Global Industry Analysis and Opportunity Assessment, 2014 – 2020”. The global diabetic food market is expected to amplify at a CAGR of 5.9% during the forecast period in terms of value due to various factors, regarding which FMI offers fundamental insights in detail in this report.
On the basis of…
Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and…
Demand for Diabetic Socks Due to Rising Prevalence of Diabetic Neuropathy Expect …
According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025.
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/19282
Global Diabetic Socks Market: Factors Impacting the Market
The primary factors driving the growth of the global diabetic socks market are increasing…
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be…
